Sargent Bickham Lagudis LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sargent Bickham Lagudis LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,0000.0%430.0%0.00%
Q1 2022$2,000
+100.0%
430.0%0.00%
Q4 2021$1,0000.0%430.0%0.00%
Q3 2021$1,000
-50.0%
430.0%0.00%
Q2 2021$2,0000.0%430.0%0.00%
Q1 2021$2,000
-50.0%
43
-50.0%
0.00%
Q4 2020$4,000
+100.0%
86
+100.0%
0.00%
Q3 2020$2,000
-33.3%
430.0%0.00%
Q2 2020$3,000
+50.0%
430.0%0.00%
Q1 2020$2,000
-33.3%
430.0%0.00%
Q4 2019$3,0000.0%430.0%0.00%
Q3 2019$3,0000.0%430.0%0.00%
Q2 2019$3,0000.0%430.0%0.00%
Q1 2019$3,000
-50.0%
43
-61.6%
0.00%
-100.0%
Q3 2017$6,0000.0%1120.0%0.00%0.0%
Q2 2017$6,000
+20.0%
1120.0%0.00%0.0%
Q1 2017$5,0000.0%1120.0%0.00%0.0%
Q4 2016$5,000
+25.0%
1120.0%0.00%0.0%
Q3 2016$4,000
+33.3%
1120.0%0.00%
Q2 2016$3,000
-40.0%
1120.0%0.00%
-100.0%
Q1 2016$5,0001120.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders